Study Exploring the Effect of Crizanlizumab on Kidney Function in Patients With Chronic Kidney Disease Caused by Sickle Cell Disease
Clinical trial NCT04053764 · COMPLETED
Trial details
- NCT number
- NCT04053764
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-10
- Primary completion
- 2023-03-20
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.